Altria revenue
Altria's revenue was $23.28bn in fiscal 2025, down 3.1% on the year before. Since fiscal 2009 ($23.56bn) it has grown at a compound -0.1% a year. Over the last twelve months it was $23.52bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.6 | 24.4 | 23.8 | 24.6 | 24.5 | 24.5 | 25.4 | 25.7 | 25.6 | 25.4 | 25.1 | 26.2 | 26.0 | 25.1 | 24.5 | 24.0 | 23.3 | 23.5 |
| Growth on the year before | — | +3.4% | −2.3% | +3.4% | −0.6% | +0.2% | +3.7% | +1.2% | −0.7% | −0.8% | −1.0% | +4.2% | −0.5% | −3.5% | −2.4% | −1.9% | −3.1% | — |
| Gross profit | 8.8 | 9.2 | 8.9 | 9.6 | 10.5 | 10.2 | 11.1 | 11.6 | 12.0 | 12.3 | 12.7 | 13.0 | 14.0 | 14.2 | 14.3 | 14.4 | 14.5 | 14.9 |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Smokeable Products | $20.5B | 88.0% | ▼ 3.4% |
| Oral Tobacco | $2.8B | 12.0% | ▲ 0.9% |
| All Other Segments | $5M | 0.0% | — |
| E Vapor | -$13M | -0.1% | ▼ 132.5% |
From Altria's 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Altria | $23.52bn | 0.5% | -1.5% |
| British American Tobacco P.l.c. | $33.78bn | 2.2% | — |
| Philip Morris International | $43.14bn | 7.9% | -9.1% |
| Universal Corp | $2.81bn | -3.6% | 2.2% |
| RLX Technology Inc. | $551m | 44.2% | — |
| Turning Point Brands, Inc. | $507m | 24.5% | 11.1% |
Compare with peers
More: Tobacco stocks compared, Consumer Staples sector, rankings of US companies